FDA approves new delivery method for MS drug
NEW YORK — The Food and Drug Administration has approved a new means of administration for a multiple sclerosis drug, the manufacturers said.
Pfizer and EMD Serono announced the approval of Rebif Rebidose (interferon beta-1a), a single-use auto-injector for self-administering Rebif, used to treat relapsing forms of MS. EMD Serono is the U.S. division of German drug maker Merck KGaA, so-named to avoid confusion with U.S.-based Merck & Co.
"We are pleased to announce the FDA has approved Rebif Rebidose, which provides people living with relapsing MS another option to meet their injection needs," EMD Serono president James Hoyes said. "The introduction of Rebif Rebidose underscores our commitment to the MS community and to our investment in the development of delivery devices to assist with ease of use and support those living with MS."
Novo Nordisk appoints Curtis Oltmans as corporate VP, general counsel for legal and quality affairs
PRINCETON, N.J. — Novo Nordisk has appointed Curtis Oltmans as its corporate VP and general counsel for legal and quality affairs, the company said Friday.
In the new role, for which he will also join the company’s U.S. executive team, Oltmans will be handle issues like law, quality, intellectual property, grants and philanthropy for the Danish drug maker’s North American business.
As VP and deputy general counsel for the company, Oltmans led the legal affairs team and was tapped in 2010 to lead the company’s Native American Health Initiative, a project to build sustainable diabetes care and education programs with the Rosebud Sioux Tribe in Rosebud, S.D.
"Curt has used his extensive knowledge of the pharmaceutical industry to make significant contributions during his tenure so far at Novo Nordisk," Novo Nordisk president Jerzy Gruhn said. "He has led our legal team through a number of significant milestones, along with overseeing an important social responsibility effort for the Native American community."
Oltmans, who began working for Novo Nordisk in 2005, previously worked for Eli Lilly and the legal firm Shook, Hardy & Bacon.
Giant-Landover donates to local breast cancer group
LANDOVER, Md. — Ahold banner Giant Food of Landover, Md., donated $37,305 to the Capital Breast Care Center.
The donation, presented by Giant-Landover public and community relations manager Jamie Miller (center) to Capital Breast Care Center executive director Wanda Lucas (front row, second from right) comes from money collected by the chain during Breast Cancer Awareness Month.
The CBCC’s stated mission is to provide comprehensive, culturally appropriate breast cancer screening services and to promote health and wellness to women in the Washington metropolitan area, regardless of their ability to pay.